20 March 2024 - The Accelerating Clinical Trials in the EU (ACT EU) initiative has established a multi-stakeholder platform aimed at improving the environment for clinical trials across the European Union.
ACT EU is a collaboration between EMA, the Heads of Medicines Agencies and the European Commission, which seeks to transform how clinical trials are initiated, designed, and run.